TRex Bio, Inc. (TRXB) SEC filings
TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.77−2.90 (-21.21%)
Close on Nov 16, 2026Market cap $16.18MP/E –Yield –
SEC filings
3 of TRex Bio's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 13, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2026 | Nov 13, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2026 | Oct 13, 2026 | SEC EDGAR |
See a number that looks wrong?